New labcorp offering makes detecting, measuring unintentional gluten consumption simple and effective

Burlington, n.c.--(business wire)--labcorp (nyse: lh), a leading global life sciences company, is the first u.s. commercial laboratory to offer a new test developed by immundiagnostik, inc. to help individuals detect and quantify unintentional gluten consumption. as awareness of celiac disease and non-celiac gluten sensitivity (ncgs) increases in the united states and around the globe, more people are adhering to strict diets to avoid gluten exposure and the negative effects it can have on thei
LH Ratings Summary
LH Quant Ranking